Share this page.

Calendar of Events

The SOT Calendar of Events contains upcoming activities hosted or sponsored by the Society, its groups, and other scientific societies, associations, or government agencies.

   or   

Active Inclusivity in Toxicology: Part 3 SOT Resources for Current Graduate Students

Organization: GSLC
Event Date or Start Date: 12/12/2019
End Date: 12/12/2019
Event Type: Other SOT Events
Country:
State or Region:
Additional Meeting Information: The Graduate Student Leadership Committee (GSLC), in collaboration with the SOT Women in Toxicology (WIT), Hispanic Organization of Toxicologists (HOT), Toxicologists of African Origin (TAO), and the Committee on Diversity Initiatives (CDI) groups, is hosting a webinar series to discuss the topic of diversity in toxicology. The series will explore issues such as unconscious bias faced by toxicologists who are members of groups underrepresented in the sciences and discuss the importance of diversity in science broadly. This series will document resources and support available in each of the relevant Special Interest Groups (SIGs) and within SOT overall.

The second session will introduce the different Specialty Interest Groups at SOT and give examples of their resources available to members. We will highlight programs within SOT that aim to promote diversity and bring additional support for members of groups underrepresented in the sciences. Three speakers from Toxicologists of African Origin (TAO), Hispanic Organization of Toxicologists (HOT), and the Graduate Student Leadership Committee (GSLC) will explore how SOT has been a resource to them during their professional development and while creating a network of fellow toxicologists. The session will showcase various opportunities SOT offers for professional development and advancing diversity.

Speakers
Enrique Fuentes-Mattei
Research Faculty
University of Texas, Division of Cancer Medicine

Alexandra Noel
Assistant Professor
Louisiana State University

Catheryne Chiang
Past CDI representative from GSLC

Registration is required.

Meeting Website: View more information

Smoke Signals: Respiratory Toxicities of Wildfire Exposures

Organization: IRSS
Event Date or Start Date: 12/13/2019
End Date: 12/13/2019
Event Type: Specialty Section Events
Country:
State or Region:
Additional Meeting Information:

Host: Inhalation and Respiratory Specialty Section (IRSS)
Date and Time: Friday, December 13, 2019, 12:00 Noon–1:00 PM (ET)

Registration is Required

Wildfires are increasing in size and severity, with severe impacts on air quality and respiratory health. Wildfire smoke is associated with increased mortality and respiratory morbidity, including increased medication usage, emergency department visits, and hospitalizations. However, the clinical impacts and molecular mechanisms are not well characterized. Therefore, defining the respiratory toxicities of wildfire exposure is critical. This webinar will introduce the epidemiological data regarding community exposures during wildfires (presented by Dr. Mary Rice), and then define the toxicological mechanisms by which wildfire smoke exposure can impact pulmonary health (presented by Dr. M. Ian Gilmour). The webinar will cover human, mouse, and in vitro studies to date.

Meeting Website: View more information

Transitioning to Independence Webinar Series Part 1: Interviews with Early Career Investigators

Organization: PDA
Event Date or Start Date: 12/16/2019
End Date: 12/16/2019
Event Type: Other SOT Events
Country:
State or Region:
Additional Meeting Information: This webinar series, sponsored by the Postdoctoral Assembly (PDA), Carcinogenesis Specialty Section (CSS), Metals Specialty Section (MSS) and endorsed by the SOT Education and Career Development Committee (ECDC), will focus on providing actionable advice on the early career transition to independence, and will feature experts with diverse backgrounds: from newly-hired assistant professors to members of faculty search committees. The target audience is trainees (postdocs and graduate students), as well as early career investigators.

Co-chairs: Sarah Carratt and Pam Lein

Co-sponsors: Postdoctoral Assembly (PDA), Carcinogenesis Specialty Section (CSS), Metals Specialty Section (MSS), Mechanisms Specialty Section

Endorsement: Education and Career Development Committee (ECDC), Graduate Student Leadership Committee (GSLC), Women in Toxicology (WIT)

Panelists
Alessandro Venosa, Ph.D.
University of Utah

Karilyn Sant, Ph.D.
San Diego State University

Jamie Bernard, Ph.D.
Michigan State University

Registration is required.

Meeting Website: View more information

Rapid Hazard Identification of Environmental Chemicals and Mixtures

Organization: RASS Monthly Webinar: Co-sponsored with the Mixtures Specialty Section
Event Date or Start Date: 1/8/2020
End Date: 1/8/2020
Event Type: Specialty Section Events
Country:
State or Region:
Additional Meeting Information:

Ivan Rusyn, MD, PhD
Department of Veterinary Integrative Biosciences
College of Veterinary Medicine & Biomedical Sciences
Texas A&M University
College Station, TX

Assessment of health effects of environmental mixtures still relies on knowledge of individual chemicals and limited animal and epidemiological studies. The traditional debate regarding the health hazard of mixtures is centered on the choice between the “additivity of dose,” or “additivity of the adverse effect.” The most recent focus in research on mixtures is on improvements in analytical techniques and exposomics, deciphering exposure-wide associations from biomonitoring data and health outcomes, and improving epidemiological methods to dissociate potential interactions among agents in a population. There has been less progress in harnessing the power of high-throughput in vitro screening to rapidly evaluate a large number of chemical combinations to identify cumulative effects, or to screen real-life environmental samples. A combination of in vitro human population-based cytotoxicity screening followed by dosimetric adjustment can inform quantitative evaluation of human health hazards from complex mixtures. This presentation will demonstrate how a multi-cell-type human in vitro model can be used for testing mixtures for rapid hazard identification and grouping with known human health hazards. Examples from disaster response scenarios will be presented to illustrate the approach.


Attendee link: https://aim-hq.webex.com/aim-hq/onstage/g.php?MTID=ef8eebb26404deea9d64a23c5c4fb9402


Teleconference information

(US & Canada Toll-Free): 1.866.469.3239
(US & Canada Toll): 1.650.429.3300
Event Number/Access Code: 734 183 696
Meeting Website: View more information

IVAMSS Webinar: 2019 Student Research Award Winners

Organization: IVAM
Event Date or Start Date: 1/9/2020
End Date: 1/9/2020
Event Type: Specialty Section Events
Country:
State or Region:
Additional Meeting Information:

Event Information: IVAMSS Webinar: 2019 Student Research Award Winners

Date and time: Thursday, January 9, 2020 11:00 am
Eastern Standard Time (New York, GMT-05:00)

Duration: 1 hour

Description:
Piecing Together the Puzzle: Identifying the Role Oxidative Stress and the Alveolar Epithelium Play in Air Pollution Induced Cardiovascular Disease
Presented by Eva Vitucci

An estimated 3.5-million people die every year from air pollution-induced cardiovascular disease (API-CVD); however, while in vivo data has demonstrated associations between induced CVD and systemic oxidative stress, the causative molecular mechanisms driving API-CVD are still poorly understood. To identify the mechanisms of action driving API-CVD, we developed a unique, tri-culture in vitro model that represents the interface of the alveolar epithelial barrier (AEB) and the cardiovascular system. We hypothesized that air pollutant exposure of human alveolar-like epithelial cells (H441) would induce oxidative stress in adjacent, but physically separated, human pulmonary vasculature cells leading to vascular damage. To test this hypothesis, we exposed confluent, electrically-resistant, and small molecular-impermeable monolayers of H441 cells, grown on the apical surface of Transwell permeable membranes, to the ubiquitous air pollutant, diesel exhaust particulates (DEP), with human lung fibroblasts on the underside of the Transwell membrane and human microvascular lung endothelial cells (HULEC) in the basal compartment. Upon DEP exposure, we identified a variety of oxidative stress responsive genes induced in the directly exposed H441 cells and in the indirectly exposed HULEC, including heme oxygenase 1 (HMOX-1) and NAD(P)H dehydrogenase [quinone] 1 (NQO1). These changes in gene expression occurred despite a lack of change in trans-epithelial electrical resistance (TEER) and small molecule (20kDa fluorescein isothiocyanate (FITC)-dextran) permeability, suggesting that they result from the release of epithelial/fibroblast-derived mediators and/or compounds/metabolites that traverse the epithelial cells. Collectively, these data suggest that induction of oxidative stress in nearby endothelial cells may be mediated by epithelial cells and may be an important mechanism of API-CVD. We conclude that we have developed a relevant, in vivo-like, in vitro model of the AEB-cardiovascular system interface which can be used to identify the elusive molecular mechanisms driving API-CVD. Ultimately, data derived from this model can be used to identify therapeutic targets, biomarkers of both susceptibility and exposure effects, and can encourage the continued development of similar biomimetic models resulting in a reduction of non-essential animal testing.

Functional Comparison of HepaRG Cells and Primary Human Hepatocytes in Monolayer and Spheroid Culture as Repeated Exposure Models for Hepatotoxicity
Presented by Jinpeng Li

Reliable and effective prediction of hepatotoxicity resulting from repeated exposure to chemicals is of critical importance for the safety assessment of chemicals. However, in vitro long-term repeated exposure studies are difficult to conduct using conventional hepatocyte monolayer cultures due to their rapid de-differentiation and subsequent loss of hepatocyte function. Towards this end, significant advancements have been made to maintain hepatic physiology for an extended period of time by culturing hepatocytes in vitro as three-dimensional (3D) spheroidal aggregates. Here, we compared two promising model systems, HepaRG and primary human hepatocytes (PHH), in both 3D spheroid and traditional 2D monolayer cultures to evaluate their potential as predictive models for assessment of hepatotoxicity. When compared to 2D cultures, cells in spheroid culture maintained higher levels of viability for a longer duration. Likewise, functional characterization revealed higher levels of xenobiotic metabolic activity (CYP1A2, CYP2B6 and CYP3A4) and urea production in spheroid vs 2D cultures. In addition, spheroid cultures showed increased sensitivity to a set of hepatotoxic compounds (ibuprofen, ibufenac, acetaminophen and aflatoxin B1) after repeated exposure (e.g., EC50 of aflatoxin B1 was reduced by 84% in PHH and 68% in HepaRG spheroids as compared to respective 2D cultures), and the sensitivity was further elevated by extended exposure duration (e.g., EC50 of aflatoxin B1 was further reduced by 25% in PHH and 73% in HepaRG spheroids when treated for an additional week). Moreover, HepaRG spheroids exhibited similar sensitivity as PHH spheroids especially in extended exposure, suggesting that HepaRG could be a reliable surrogate for PHH and serve as a repeated exposure model to predict hepatotoxicity.

Registration is required.

Meeting Website: View more information

Best of the Dermal Toxicology Specialty Section: 2019 Scientific Award Winners

Organization: DTSS
Event Date or Start Date: 1/13/2020
End Date: 1/13/2020
Event Type: Specialty Section Events
Country:
State or Region:
Additional Meeting Information:

Event Information: DTSS Webinar: Best of the Dermal Toxicology Specialty Section: 2019 Scientific Award Winners

Date and time: Monday, January 13, 2020 1:00 pm
Eastern Standard Time (New York, GMT-05:00)

Duration: 2 hours

Description:
The Dermal Toxicology Specialty Section presents annual awards for scientific studies related to toxicity of the skin. In 2019, three winners were chosen from the members of this section based on their scientific accomplishments. The objective of this webinar is for the winners to showcase their award-winning research.

The first presentation will be by Dr. Yoke-Chen Chang who, along with her co-authors, was awarded the DTSS Paper of the Year Award. This work investigated the expression of cytokines and chemokines in mouse skin treated with the chemical warfare agent sulfur mustard. They found that inflammatory cell-derived mediators contribute to the pathogenesis of sulfur mustard induced skin damage.

The second presentation will be by Dr. Xue (Lucia) Liu. She and her collaborators developed a novel bio-printed vascularized full thickness skin equivalent and a reconstructed human epidermis in a multi-well plate format. The purpose for the development of these 3-dimensional tissue models is for high-throughput drug screening. The tissues developed in this study offer an in vitro approach for understanding the pharmacologic and toxicologic mechanism of action of drugs applied to the skin.

The third presentation will be by Ms. Sarah Dickinson. Recent evidence suggests that sunscreens, used to protect the skin from damaging ultraviolet radiation from the sun, have off-target effects. The results from this study suggest that the sunscreen octinoxate modulates AhR activity via inhibition of cytochrome P450 1A1. Alteration of AhR activity and signaling has many potential implications on the functions of skin.

Speakers
Yoke-Chen Chang, PhD
Rutgers University

Xue (Lucia) Liu, PhD
NIH

Sarah Dickinson
University of Rochester

Registration is required

Meeting Website: View more information

Microbiome: The Missing Piece in the Diet/Health Puzzle

Organization: SOT Food Safety Specialty Section (FSSS)
Event Date or Start Date: 1/15/2020
End Date: 1/15/2020
Event Type: Specialty Section Events
Country:
State or Region:
Additional Meeting Information:

Event Information: FSSS Webinar: Microbiome: The Missing Piece in the Diet/Health Puzzle

Date and time: Wednesday, January 15, 2020 11:00 am
Eastern Standard Time (New York, GMT-05:00)

Duration: 1 hour 30 minutes

Description: Appropriate mutualistic and commensal host/microbiome interactions provide beneficial effects to one or both species, while adverse host/microbiome interactions contribute to disease. Two speakers will describe the effects of diet and foodborne agents on gut microbiota and the effects of gut dysbiosis on health.

Speakers:

Tiffany Weir, PhD

The gut microbiota has emerged as an important regulator of human health. Imbalances in the gut microbiota, referred to as dysbiosis, have been associated with numerous disease both within the intestines as well as in peripheral tissues in organs. Gut dysbiosis is often characterized by reduced microbial diversity and loss of functionality and can lead to increased intestinal inflammation and loss of gut barrier function. While numerous factors can impact the intestinal microbiota, including age, stress, medications, pollutants, and exercise- diet has the greatest potential to modify the microbiota. Our laboratory studies how diet-induced alterations to the microbiota can prevent or increase the risk of developing cardiometabolic diseases. In this webinar, we will explore the role the microbiota plays in disease development and examine some of the underlying mechanism and how external factors shape the microbiota with a focus on dietary components.

Sangeeta Khare, Ph.D.

This talk will provide approaches for the risk assessment of intentional and unintentional use of antimicrobials (metal-based nanomaterial) and antimicrobial residues (antibiotics). Usually these products are used as health supplements or are present as drug residues in consumer products. Interactions of these products with the gastrointestinal tract might have an adverse effect on the commensal microbiota, impact antimicrobial resistance and alter the host immune responses and intestinal permeability.

Registration is required to join this event.

Meeting Website: View more information

Impact of 2017/745 EU Medical Device Regulation (MDR) on Biological Evaluation of Medical Devices

Organization: MDCPSS
Event Date or Start Date: 1/16/2020
End Date: 1/16/2020
Event Type: Specialty Section Events
Country:
State or Region:
Additional Meeting Information:

Event Information: MDCPSS Webinar: Impact of 2017/745 EU Medical Device Regulation (MDR) on Biological Evaluation of Medical Devices

Date and time: Thursday, January 16, 2020 11:00 am Eastern Standard Time (New York, GMT-05:00)

Duration: 1 hour

Description:
This webinar will focus on the impact of the 2017/745 EU Medical Device Regulation (MDR) on biological evaluation of medical devices. The webinar will compare relevant MDR General Safety and Performance Requirements (GSPR) with the Medical Devices Directive (MDD) Essential Requirements; compare MDR GSPR with ISO 10993 and ISO 14971; and discuss the impact of changes in ISO 10993-1:2018 and other ISO standards. A generous Q&A session is planned to accommodate conversation with the speaker—Chairman of ISO/TC 194 Biological Evaluation and Director of Regulatory Consultancy and Quality Assurance at an EU Authorized Representative, regulatory consultancy, and CRO.

Speakers
Jeremy Tinkler
Director of Regulatory Consultancy and Quality Assurance
MedPass International SAS

Rachel Hardy
Senior Strategy Consultant
MedPass International SAS

Registration is required.

Meeting Website: View more information

9th Trial Master File Summit

Organization: ExL Events
Event Date or Start Date: 1/21/2020
End Date: 1/23/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: FL
Additional Meeting Information: The 9th Trial Master File Summit offers attendees premier networking opportunities, access to the TMF community, and endless amounts of critical information to bring back to their teams. Summit participants return to work informed, equipped, and inspired to guide their organization’s TMF to its full potential! New features of this year’s program include:

- Increased perspective from CROs
- Representation from regulatory authorities
- Functional implementation of TMF systems
- Risk-based monitoring and processes
- Exploring functional areas and their teams
- Innovations and advancements in technology
- Collaboration with clinical sites

Venue Details: Sheraton Orlando Lake Buena Vista Resort, 12205 South Apopka Vineland Road, Orlando, 32836, United States

Date and Time: On Tuesday January 21, 2020 at 9:00 am ends Thursday January 23, 2020 at 5:00 pm

Meeting Website: View more information

12th Risk Evaluation and Mitigation Strategies Summit (REMS)

Organization: ExL Events, a division of Questex
Event Date or Start Date: 1/21/2020
End Date: 1/22/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: VA
Additional Meeting Information: The 12th REMS Summit convenes pharma, FDA, healthcare providers, and patient advocates to delve into specific topics to enhance the understanding of when REMS are necessary the elements that need to be included in the REMS needed for their product, as well as details required for submission. Our adept speaking faculty will arm you with proven strategies to facilitate benefit-risk counseling, optimize REMS operations through streamlined health system integration, leverage interoperable technologies for consistent communication, and increase patient safety through cross-functional collaboration.

Top Five Reasons to Attend:
*To assess REMS efficacy with proven methods from industry professionals
*Complying with regulations pertaining to standardization and evaluation
*Collaborate with industry leaders on innovative approaches for REMS design, implementation, and solutions
*Increase knowledge and awareness of upcoming REMS technologies, innovation and regulatory changes
*Discussing the challenges of recent FDA guidelines impacting REMS

Who Should Attend:
This event is ideal for professionals from payers and pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas:

REMS
Risk Management
Pharmacovigilance/Surveillance
Quality Assurance
Drug/Product Safety
Clinical Risk Management
Lifecycle Management
Regulatory Affairs/Legal/Compliance
Clinical Affairs
Clinical Data Management
Clinical Operations
Clinical Risk Management Compliance
Epidemiology/Pharmacoepidemiology
Marketing

Meeting Website: View more information

CSS Webinar: Part 1 - Mechanistic Assessment of Carcinogenicity

Organization: Carcinogenesis SS
Event Date or Start Date: 1/24/2020
End Date:
Event Type:
Country:
State or Region:
Additional Meeting Information: For decades, risk assessors have relied on the rodent cancer bioassays to collect apical endpoints that are used to identify potential human carcinogens. The rat and mouse bioassays are currently required by regulatory authorities for carcinogenicity assessment of agrochemicals, pharmaceuticals, and environmental pollutants. However, five decades of cancer research have revealed more informative, human-relevant approaches to assess potential carcinogenic effects. Questions are now being asked about how to modernize cancer risk assessment with mechanistic approaches that reduce testing on animals and provide more human health– protective information to ensure chemical safety. This webinar series will address these questions as cross-sector experts deliver webinar presentations that will provide insight into current challenges and opportunities in designing human-relevant chemical carcinogenicity assessment. The webinar series will focus on two key areas: mechanistic assessment of carcinogenicity and modernization of cancer risk assessment. For each of these webinars, we will address the relevant aspects of emerging technology, strategic and tactical issues, and regulatory guidance relevant to safety and risk assessment. The focus of these webinars will be to demonstrate opportunities to modernize chemical carcinogenicity assessment to provide human health protection while reducing testing on animals. This webinar series could potentially run every other year as guidelines and scientific thinking evolve. This webinar series is based on several ongoing, high-profile research projects focused on modernizing carcinogenicity assessment in place of the rodent cancer bioassays. Additionally, this timely topic is the subject of numerous conference workshops, demonstrating interest from the scientific community across various sectors and regulatory bodies. Structure: The intention is to deliver the content as two successive webinars, with a Q&A panel session at the end of the last webinar. The moderator for each webinar can accumulate key questions and learning points to be shared in and built into a course commentary and/or Q&A.

Registration is required.

Meeting Website: View more information

Commercializing Continuous Processing in Pharma

Organization: Hanson Wade
Event Date or Start Date: 1/28/2020
End Date: 1/30/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: MA
Additional Meeting Information: Safety, Efficacy, Efficiency and Quality: Scaling Your Continuous Processing from Technology to Commercial Manufacturing

Four years in the drug development world isn’t long, and the progress made in continuous processing has been an extraordinary. Thanks to the encouragement of the FDA and maturing technology; both pharma and biotech are starting to adopt continuous manufacturing (CM) in a commercial setting.

Over the last 12 months we have seen major milestones in continuous manufacturing globally – PROSPECT project in the UK, GSK’s announcement of CM facilities in Singapore, Merck has filed an NDA under CM approach, Bill and Melinda Gates Foundation granted $14.3m to Univercells to deploy CM for measles and rubella vaccine continuous manufacturing.

At the 4th Annual CCP Summit we will continue to explore scientific and technology advancements that can help eliminate bottlenecks, and more importantly, will address the quality, upfront investment and business rationale behind the ‘switch’.

Returning to Boston for the 4th time on Jan 28 – 30, 2020 – Get involved now!
Meeting Website: View more information

NAMs Case Study : Industry/Government Partnerships

Organization: IVAM
Event Date or Start Date: 1/29/2020
End Date: 1/29/2020
Event Type: Specialty Section Events
Country:
State or Region:
Additional Meeting Information:

Event Information: IVAM-SS Webinar: NAMs Case Study : Industry/Government Partnerships

Date and time: Wednesday, January 29, 2020 11:00 am
Eastern Standard Time (New York, GMT-05:00)

Duration: 1.5 hour

Description:
This webinar will use a case study to discuss the process of leveraging industry/regulatory partnerships to work more efficiently and effectively as we forge ahead in the NAMs space. We will have two speakers, Monique Perron from US EPA, and Doug Wolf from Syngenta. The speakers will discuss the processes they took as they worked through an alternative approach to the 90-day inhalation animal study, highlighting key watch-outs and suggestions from their experience.

Presenters
Monique Perron, Sc.D
Acting Branch Chief, Risk Assessment Branch IV
US EPA, OPP, HED

Douglas C. Wolf, DVM, PhD, FIATP, ATS
Senior Syngenta Fellow, Product Safety

Registration is required

Meeting Website: View more information

Challenges and Opportunities in Assessing Health Risk from Unconventional Oil and Gas Development

Organization: RASS Monthly Webinar: Co-sponsored with the International Society of Exposure Science
Event Date or Start Date: 2/12/2020
End Date: 2/12/2020
Event Type: Specialty Section Events
Country:
State or Region:
Additional Meeting Information:

Donna Voorhees, PhD
Director of Energy Research
Health Effects Institute (HEI)
Boston, MA


Onshore development of oil and natural gas from unconventional resources (unconventional oil and gas development, abbreviated in this presentation as “UOGD”) has expanded rapidly in the United States during the last decade and, along with it, concern about its potential health effects. While UOGD shares many attributes of conventional oil and gas development that has been around since the 1800s, it is occurring in locations and at a scale not always familiar to those living nearby. This presentation will summarize methodologic challenges and opportunities in understanding the potential for health effects, especially through risk-based analyses.

Beginning in 2012, academic scientists and public health authorities published human health risk assessments and risk-based screening assessments that combined information about potential UOGD-related chemical concentrations with relevant toxicity information to predict risk to communities in Colorado, North Dakota, Pennsylvania and the broader Marcellus region, Texas, and Wyoming. Nearly all assessments quantified risk to community members associated with potential exposure to UOGD-related chemicals in air, but several assessed risks involving water. Assessments varied in their complexity, from screening-level comparisons of chemical concentrations, to health-based benchmarks, to more involved assessments measuring potential exposure specific to a population, including control for baseline, or background, conditions. Conclusions differed among the risk assessments and were subject to important sources of uncertainty about exposure and toxicity and the judgments made by investigators to address them. The body of work also was limited in its relevance to operations, regions, and populations beyond those that were the subject of each assessment. Future investigators must grapple with the extensive temporal and spatial variability in potential exposure as a function of numerous factors (e.g., differences in regulations, environmental conditions, and practices among UOGD operators), the uncertainties about potential exposure (e.g., when and where will operations happen, the identity of chemicals being used, the efficacy of noise mitigation), and the lack of toxicity information for some chemicals associated with UOGD operations.


Attendee link: https://aim-hq.webex.com/aim-hq/onstage/g.php?MTID=e0b19ebc74ab20119aa26b401f6f6be06

Teleconference information

(US & Canada Toll-Free): 1.866.469.3239
(US & Canada Toll): 1.650.429.3300
Event Number/Access Code: 731 407 840
Meeting Website: View more information

3rd international conference on Industrial Biotechnology and Bioprocessing

Organization: Allied Academies
Event Date or Start Date: 2/17/2020
End Date: 2/18/2020
Event Type: Other Scientific Events
Country: FRANCE
State or Region:
Additional Meeting Information:
Meeting Website: View more information

4th International Conference on Chronic Diseases

Organization: Pulsus Conferences
Event Date or Start Date: 2/17/2020
End Date: 2/18/2020
Event Type: Other Scientific Events
Country: FRANCE
State or Region:
Additional Meeting Information:

It takes immense pleasure to invite you to attend 4th International Conference on Chronic Diseases (Chronic Diseases 2020) scheduled to be held in Paris, France during February 17-18, 2020.
Chronic Diseases 2020 is a global event focusing on the immense knowledge and major advances in the rapidly emerging fields of chronic diseases by attracting experts and professionals across the universe.

Visit: https://chronicdiseases.cmesociety.com/

Meeting Website: View more information

15th Annual Biomarkers Congress

Organization: Oxford Global
Event Date or Start Date: 2/18/2020
End Date: 2/20/2020
Event Type: Other Scientific Events
Country: UNITED KINGDOM
State or Region:
Additional Meeting Information: Join us to network at the Europe's Leading Biomarker Forum: 15th Annual Biomarkers Congress and co-located Genomic Markers Congress, 18 - 20 February 2020 in London.

Oxford Global is proud to present for the 15th year our flagship Biomarkers Series UK, 18 – 20 February 2020, Manchester, UK. This year promises to be the most exciting Biomarkers Series to date, with a host of new features alongside the popular programme to ensure you gain vital updates on the latest biomarker initiatives and technologies.

With over 100 presentations, the event is designed to provide a comprehensive look at biomarker research from early discovery through to the clinic across multiple therapeutic areas, including oncology, neuroscience, immunology and cardiology. Further sessions focus on topical technological innovation in this space: diagnostic development, imaging, proteomics and immunoassays.

Featuring the following interactive streams:

- Biomarkers in Drug Discovery & Development – Therapeutic Areas: Oncology, Immuno-Oncology and Immunology
- Biomarkers in Drug Discovery & Development – Therapeutic Areas: Neuroscience, Cardiovascular Disorders and Rare Disease
- Biomarkers for Detection, Monitoring & Diagnosis
- New Biomarker Technologies & Data
- Biomarkers for Clinical Development
- Biomarkers for Preclinical Development

New for 2020, we are pleased to announce the following features:

- The Inaugural Genomic Markers Congress: Two dedicated streams on the integration of genomic markers into drug development to enable precision medicine
- A pre-event focus day: Deep-dive sessions in the morning to provide insights into key therapeutic areas from leading experts and end-user workshops in the afternoon to showcase key platforms to incorporate in your workflow. Spaces are limited, so sign-up early to avoid disappointment
- Our Day 1 workshop on Biomarker Qualification: Technical Validation and Regulatory Aspects
- Our Day 2 workshops on Data Analysis and Bioinformatics and Genomic Biobanking to Facilitate Precision Medicine

On Tuesday February 18, 2020 at 7:00 am (ends Thursday February 20, 2020 at 7:00 pm)

Meeting Website: View more information

SMi's 4th Annual 3D Cell Culture Conference

Organization: SMi Group
Event Date or Start Date: 2/18/2020
End Date: 2/20/2020
Event Type: Other Scientific Events
Country: UNITED KINGDOM
State or Region:
Additional Meeting Information: CHAIRED BY:
Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
Stefan Przyborski, Professor of Cell Technology, Durham university

Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.

Bioprinting has become increasingly efficient and accurate in building in vitro tissue models with the potential to provide pathologically relevant responses and model human disease mechanisms. Bio-printed structures yield phenotypic endpoints that are comparable with clinical studies and can provide a realistic prediction of clinical efficacy. The use of bioprinting is growing in big pharma companies as an alternative to organ-on-a-chip systems.

For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.

WHO SHOULD ATTEND?
Biotech / Pharma Companies - Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist
Academia Professor - Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director

Meeting Website: View more information

CSS Webinar: Part 2 - Modernization of Cancer Risk Assessment

Organization: Carcinogenesis SS
Event Date or Start Date: 2/19/2020
End Date:
Event Type:
Country:
State or Region:
Additional Meeting Information: Description:
For decades, risk assessors have relied on the rodent cancer bioassays to collect apical endpoints that are used to identify potential human carcinogens. The rat and mouse bioassays are currently required by regulatory authorities for carcinogenicity assessment of agrochemicals, pharmaceuticals, and environmental pollutants. However, five decades of cancer research have revealed more informative, human-relevant approaches to assess potential carcinogenic effects. Questions are now being asked about how to modernize cancer risk assessment with mechanistic approaches that reduce testing on animals and provide more human health– protective information to ensure chemical safety. This webinar series will address these questions as cross-sector experts deliver webinar presentations that will provide insight into current challenges and opportunities in designing human-relevant chemical carcinogenicity assessment. The webinar series will focus on two key areas: mechanistic assessment of carcinogenicity and modernization of cancer risk assessment. For each of these webinars, we will address the relevant aspects of emerging technology, strategic and tactical issues, and regulatory guidance relevant to safety and risk assessment. The focus of these webinars will be to demonstrate opportunities to modernize chemical carcinogenicity assessment to provide human health protection while reducing testing on animals. This webinar series could potentially run every other year as guidelines and scientific thinking evolve. This webinar series is based on several ongoing, high-profile research projects focused on modernizing carcinogenicity assessment in place of the rodent cancer bioassays. Additionally, this timely topic is the subject of numerous conference workshops, demonstrating interest from the scientific community across various sectors and regulatory bodies. Structure: The intention is to deliver the content as two successive webinars, with a Q&A panel session at the end of the last webinar. The moderator for each webinar can accumulate key questions and learning points to be shared in and built into a course commentary and/or Q&A.

Registration is required.

Meeting Website: View more information

RNA Therapeutics

Organization: SMi Group Ltd
Event Date or Start Date: 2/19/2020
End Date: 2/20/2020
Event Type: Other Scientific Events
Country: UNITED KINGDOM
State or Region:
Additional Meeting Information: This year, we will maintain our focus on the latest research and developments on delivery system technologies that aim to tackle more difficult targets within the human body. This overarching topic warrants high focus and therefore we will, for the first time in the series, introduce a focus day on Oligonucletide Delivery Systems. Our main conference will focus on current developments in the area of mRNA therapeutics in immunotherapy and vaccination. We will also cover a fair bit of regulation, such as continuing upon patenting novel products, release of new 2020 regulations in the clinical trials arena, as well as ensuring compliance. Finally, a significant section that tackles novel and emerging therapies as well as the latest research findings from academia will also be present in this year's agenda.
Meeting Website: View more information

4th World Congress and Expo on Cell and Stem Cell Research

Organization: http://stemcell.alliedacademies.com/
Event Date or Start Date: 2/21/2020
End Date: 2/22/2020
Event Type: Other Scientific Events
Country: FRANCE
State or Region: ile-de-france
Additional Meeting Information:

For Registration: http://stemcell.alliedacademies.com/registration

Contact Details:

Leon Bezos,
Program Director,
Stem Cell 2020,
E: stemcellcongress@geneconferences.com
Tel: (+44) 2037691755
What's App: (+44) 1403582077

Meeting Website: View more information

Antibody Engineering and Therapeutics ASIA

Organization: KNect365
Event Date or Start Date: 2/24/2020
End Date: 2/26/2020
Event Type: Other Scientific Events
Country: JAPAN
State or Region:
Additional Meeting Information: World-renowned scientists sharing the latest technologies, RandD and clinical data to fast-track your next-generation therapeutics towards commercial success.

7 Conference Session Themes:
- Novel Engineering and Discovery Strategies
- ADCs/Antibody-Drug Conjugates
- Bispecific Antibodies and Multi-Functional Biologics
- Immuno-Oncology
- Preclinical and Clinical Case Studies
- Delivery Strategies and Crossing/Penetrating Biological Barriers
- Engineering Strategies for TCR and CAR T Cell Therapies

Meeting Website: View more information

Nano Pharmaceuticals 2020

Organization: Conferenceseries LLC Ltd
Event Date or Start Date: 2/24/2020
End Date: 2/25/2020
Event Type: Other Scientific Events
Country: ITALY
State or Region:
Additional Meeting Information: Conferenceseries LLC Ltd cordially welcome to “3rd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine” scheduled to be held during February 24-25, 2020, Rome, Italy. This Nano Pharmaceuticals 2020 Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. The conference invites delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Nano Pharmaceuticals 2020 International conference will be an excellent opportunity to meet eminent personalities.
For more details PS: https://nanomedicine.pharmaceuticalconferences.com/usa
Meeting Website: View more information

AI-ML Drug Discovery and Development Summit

Organization: Hanson Wade
Event Date or Start Date: 2/24/2020
End Date: 2/26/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: CA
Additional Meeting Information: The 3rd Annual AI-ML: Drug Discovery and Development Summit is the industry's definitive guide to translating the wealth of tech available to successful, efficacious and efficient RandD processes. With 3 days of real-world case studies, this summit will provide the roadmap to augmented RandD decision making with reduced failure rates, increased speed and improved margins.

This year's summit will take a deeper look at:

- Target, pathway and molecule selection - identifying which will treat individual disease indications better
- Predictive preclinical models - knowing from the beginning how drug candidates will react when administered to in vivo and in vitro models
- Identification of the patients who will react best to the treatment with minimal side effects for a guaranteed successful clinical trial
Join 80+ like-minded peers to overhaul RandD and reflect on the lessons learned from the successes and mistakes made from a year of implementation and utilization.

Walk away with a blueprint for more accurate, more efficient and more effective RandD processes.

Download the Full Event Guide to get a taste of the real-world case studies you'll be joining at the conference.
Meeting Website: View more information

RAS- Targeted Drug Discovery Europe Summit

Organization: Hanson Wade
Event Date or Start Date: 2/25/2020
End Date: 2/27/2020
Event Type: Other Scientific Events
Country: AUSTRIA
State or Region: Wien
Additional Meeting Information: After three decades of trial and error to target the driver of 30% of all diagnosed cancers, scientists are finally making meaningful clinical progression to target the cancer master switch, the RAS family of proteins. The RAS- Targeted Drug Discovery Summit Europe is the only industry and translational focused platform dedicated to bringing you innovative anti-RAS drug discovery science, capturing the most pioneering data, thought-provoking insights and practical lessons learned, enabling you to maximise the clinical therapeutic window of your anti-RAS candidate.

Uniting the leading minds from large pharma, biotech and academia, this summit will help you advance novel target site discovery, improve drug-like properties and accelerate the translation of potent and mutation-specific RAS targeted therapeutic strategies into human clinical trials. With numerous approaches emerging that demonstrate genuinely viable efficacy in targeting the RAS family of proteins, join the RAS- Targeted Drug Discovery Summit Europe to gain first-hand insights on the challenges and strategies to robustly translate promising anti-RAS therapies into the clinic.

Meeting Website: View more information

Developing Medical Countermeasures To Treat the Acute and Chronic Effects of Ocular Chemical Toxicity - A Trans Agency Scientific Meeting

Organization: National Institutes of Health (NEI and NIAID)
Event Date or Start Date: 2/25/2020
End Date: 2/26/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: MD
Additional Meeting Information:

Target Audience:

  • Academic, industry and government researchers engaged in developing therapeutic approaches and medical countermeasures (MCMs) against ocular pathologies resulting from exposure to chemical toxicants
  • Government stakeholders and funding agencies

Objectives of the Scientific Meeting:

  • Development of MCMs that mitigate acute and chronic corneal manifestations in response to ocular toxicants relies on the development of well-characterized experimental models with defined pathophysiology that allow for effective bridging to humans. Such models are also essential to demonstrate therapeutic efficacy.
  • This meeting will bring together subject matter experts from the civilian and military research communities to discuss the current state of the field, including potential therapeutic approaches and available models.
  • Attendees of the workshop will contribute to our understanding of pathologies and models available for studying toxic ocular injuries and their utility in the research and development of therapeutics. Most importantly, the workshop will address current knowledge gaps to identify possible refinements or new directions to advance MCM development.

Session Topics:

  • Acute and Chronic Responses to Corneal Toxicity
  • Mechanistic Basis of Corneal Pathophysiologies and Wound Healing
  • Therapeutically Accessible Models of Corneal Toxic Injury
  • Therapeutic Approaches to Mitigate Corneal Pathophysiologies
  • Current Research/Development Perspectives and Resources for Researchers
  • Meeting Wrap Up

Organizers:

  • National Eye Institute (HHS/NIH/NEI)
  • U.S. Army Medical Research Institute for Chemical Defense (DoD/USAMRICD)
  • National Institute of Allergy and Infectious Diseases (HHS/NIH/NIAID)

Opportunities for travel awards, oral and/or poster presentations are available - see

Meeting Website: View more information

5th German Pharm-Tox Summit

Organization: Conventus
Event Date or Start Date: 3/2/2020
End Date: 3/5/2020
Event Type: Other Scientific Events
Country: GERMANY
State or Region:
Additional Meeting Information:
Meeting Website: View more information

Annual Dentistry and Dental Sciences Congress

Organization: Pulsus group
Event Date or Start Date: 3/2/2020
End Date: 3/3/2020
Event Type: Other Scientific Events
Country: UNITED KINGDOM
State or Region:
Additional Meeting Information: Annual Dentistry and Dental Sciences Congress comprises of proficient keynote presentations, verbal speeches, productive poster presentations and exhibitions providing insights to the importance and efficiency of dentistry in Healthcare. The conference takes place in Edinburgh, Scotland during March 2-3, 2020. The theme of the conference is “Escalating the research ideas in dentistry and dental sciences”. The sessions involved in the conference is Dentistry, Oral care, Dental Nursing, Orthodontics, Forensic Odontology, Nano dentistry, Paediatric dentistry, Cosmetic dentistry, Dental Physics science, Etc., The forum is to establish the research ideas and recent technology in the field of dental and oral field. The dental conference will give you a great experience and networking with the eminent people.
Meeting Website: View more information

INTERNATIONAL CONFERENCE ON NUTRACEUTICALS

Organization: Herald Meetings
Event Date or Start Date: 3/2/2020
End Date: 3/3/2020
Event Type: Other Scientific Events
Country: ITALY
State or Region:
Additional Meeting Information: Herald Meetings welcomes you to attend International Conference on Nutracueticals going to be held in May 02-03, 2020 at Rome, Italy. We invite you to join us at the Nutracueticals 2020, where you will be sure to have knowledge with scholars from around the world for a good health. World-renowned speakers, the most recent methods, progresses, and the newest updates in Euro Nutracuetical 2020 are hallmarks of this conference.
Nutraceuticals 2020 objective is to bring together all Nutracueticals professionals and academicians from all areas of Nutrition, Nutracueticals and associated disciplines. We are sure that the International Conference on Nutracuetical will be a unique opportunity for high quality scientific program with session lectures, symposia, workshops, poster presentations and different programs for participants from throughout the world.
Meeting Website: View more information

Environmental pollution risks in developing countries (EPRDC 2020)

Organization: Beni-Suef University, Egypt
Event Date or Start Date: 3/3/2020
End Date: 3/4/2020
Event Type: Other Scientific Events
Country: EGYPT
State or Region: Beni Suef province
Additional Meeting Information:

Invitation


Dear Colleagues,
On behalf of Beni- Suef University, Egypt, we are delighted to invite all scientists from academia and industry and representatives of national and international agencies, to attend the International conference: Environmental Pollution Risks in Developing Countries (EPRDC 2020)
Under the Patronage of:
Prof. khaled Abdul Ghaffar –Minister of Higher Education and Scientific Research
Prof. Mansour Hasan- President , Beni - Suef University
Prof. Badr Nabeh, Vice President, Beni Suef University
Prof. Khaled Abbas Helmy Abdou General Secretary, Beni Suef University

Conference theme:


Environmental pollution risks in developing countries (EPRDC 2020)
?????? ?????? ??????? ?? ??????? ???????
3 – 4 MARCH, 2020 - Beni Suef University, Egypt

Objectives:
1. Exchange the state of the art on climate change and environmental sciences.

2. Gathering scientific information and experiences in order to identify the common and urgent environmental issues in developing countries.

3. Promote partnerships between different sectors for collaboration to protect the environment in developing countries.

4. Exchange the knowledge related to the new green technology aspects.

5. To increase the public awareness about the environmental challenges facing human health in developing countries.

Topics:
1- Environmental pollution.

2- Environmental risk management.

3-Innovative technologies of environmental monitoring.
4-water quality and wastewater management .
5- Environmental pollution and food safety.
6- Renewable energy.
7- Waste management and sustainability.
8- Green chemistry
9- Climate changes and environmental hazards.
The organizers of the International Symposium on environmental pollution risks in developing countries (EPRDC 2020) promise to prepare a balanced programme including oral presentations workshops, , interactive seminars and nice social events.
We are looking forward to meeting you again in Egypt

• Registration and payment information:
Fee:
Participant
category Early registration Late registration
Egyptians
(LE) Non Egyptians
($) Egyptians
(LE) Non Egyptians
($)
Non-Bsu Participants 300 300 350 350
BSU- members 150 150 200 200
Student 100 100 150 150

- Payment by cash to the Beni- Suef University (9/450/87972/7).
- Deadlines
1-Early registration:31 December 2019.
2- submission of abstracts and late registration : 15 February 2020

Guidelines for submission
Poster submission :
Please ensure your poster does not exceed the poster board dimensions; 75 cm wide x 100 cm high
Oral submission:
Microsoft power point or PDF
Abstract submission
Font size 12, Normal, Times New Roman, 1.5 space
• Official languages: English- Arabic
Contact us:

Conference Secretary:
- RAGAA AZZAT : 01002679489
- DALIA ELFOULY: 01068813441
- Amro Mohamed : 01000086960

Get in touch :
Web site : www.eprdc2020. bsu .edu.eg
Face book: https://www.facebook.com/EPRDC2020
EMAIL : eprdc2020@bsu.edu.eg


Meeting Website: View more information

NYC Exposomics Symposium

Organization: Mount Sinai School of Medicine
Event Date or Start Date: 3/5/2020
End Date: 3/6/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: NY
Additional Meeting Information:

Travel Grants for Trainees available

Early bird registration deadline: December 13, 2019

Call for Poster Deadline: January 31, 2020

Keynote Addresses

Linda Birnbaum PhD, NIEHS director (retired)

Dean P Jones PhD, Emory University

visit

Meeting Website: View more information

Inborn Errors of Metabolism Drug Development Summit 2020

Organization: Fergus Cunningham
Event Date or Start Date: 3/10/2020
End Date: 3/12/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: MA
Additional Meeting Information: Join over 80 inherited metabolic disease drug developers and KOLs to explore how the key challenges prohibiting accelerated drug development are being addressed. The inaugural Inborn Errors of Metabolism Drug Development Summit will provide a discursive platform to examine where pioneering gene therapy modalities intersect with current therapeutic options and explore how diseases can be better targeted in order to address the huge unmet medical need for rare metabolic diseases.

With scarce treatment options leaving inborn errors of metabolism a devastating, unfilled and unmet medical need, the opportunity for biopharma to do better and aggressively tap into a lucrative and life changing market of gene modalities is growing. For the first time, the Inborn Errors of Metabolism Drug Development summit will look to examine how the experience within existing pharmacology for rare metabolic diseases can be leveraged with the drug development strategies of those pioneering gene modalities to improve efficacy, safety and commercial viability.

Incorporating insights from industry-leading speakers, this conference will delve into the key patient access, regulatory, clinical and commercial hurdles that need to be overcome in order to address the unmet medical need of rare metabolic diseases and fulfil their full commercial potential.

This is your comprehensive guide to define your drug development path for 2020. Don’t miss out on your chance to network with industry leaders and be a part of the only enriched industry forum focused on accelerating the development of better effective treatments for inborn errors of metabolism.

Meeting Website: View more information

SOT 59th Annual Meeting and ToxExpo

Organization: Society of Toxicology (SOT)
Event Date or Start Date: 3/15/2020
End Date: 3/19/2020
Event Type: Other SOT Events
Country: UNITED STATES
State or Region: California
Additional Meeting Information: Taking place in Anaheim, California, the SOT 59th Annual Meeting and ToxExpo will feature more than 80 Scientific Sessions, 2,000 presentations, 300 exhibitors, and 6,000 attendees.
Meeting Website: View more information

3rd international conference on obesity and weight loss 2020

Organization: Madridge Publishers
Event Date or Start Date: 3/19/2020
End Date: 3/20/2020
Event Type: Other Scientific Events
Country: ITALY
State or Region: Rome
Additional Meeting Information: 3rd International Conference on Obesity and Weight Loss is going to be held during March 19-20, 2020 at Rome, Italy. We cordially invite all the participants who are interested to share and discuss their knowledge and research in the area of Obesity & Weight Loss.

Obesity-2020 conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations.

This 3rd International Conference on Obesity and Weight Loss will provide an opportunity for researchers, doctors, practitioners, and educators to exchange research evidence, practical experiences and innovative ideas on issues related to Obesity & Weight Loss. It is a global platform to explore issues of mutual concern as well as the exchange of knowledge, share evidence, ideas, and knowledge.
Meeting Website: View more information

2nd International Conference on Cell & Gene Therapy

Organization: Allied Academics
Event Date or Start Date: 3/23/2020
End Date: 3/24/2020
Event Type: Other Scientific Events
Country: NETHERLANDS
State or Region:
Additional Meeting Information: Gene Therapy2020: The world’s largest Cell and Gene Therapy Conference and Gathering for the Research Community, Join the Gene Therapy Conference at Amsterdam, Netherlands. The conference is based on the Theme of Reconnaissance of Peculiar Research and Innovation on Cell and Gene Therapy. The conference which will be held on March 23-24, 2020, Amsterdam, Netherlands. This conference gives you a great experience and it will give you a key to open the knowledge and technology on Cell and Gene Therapy. The people who are attending this program gets benefitted by the hearing the speech from the eminent scientist, authorized people, and the businesspeople. This conference gives you a fascinating idea and it will help you to get connected with the academic and businesspeople.
Meeting Website: View more information

IPVC 2020: 33rd International Papillomavirus Conference

Organization: International Papillomavirus Society
Event Date or Start Date: 3/23/2020
End Date: 3/27/2020
Event Type: Other Scientific Events
Country: SPAIN
State or Region: Barcelona
Additional Meeting Information: The 33rd International Papillomavirus Conference and Basic Science, Clinical and Public Health Workshops will be held in Barcelona, Spain from March 23-27, 2020.

The theme of the Conference is “Science and education for action against HPV”. Through workshops, lectures, oral and poster sessions presenting the latest research results, the program will cover papillomavirus (PV)-related topics from basic science to global health impact. We will be paying special attention to HPV prevention and control in populations that are most vulnerable to HPV disease worldwide, including those in Low- and Middle-Income Countries.

In line with the IPVS mission of addressing the most recent advances across the spectrum of PV research, conference themes will across 3 tracks - Basic Science, Clinical Research, and Public Health / Epidemiology - including:
- Epidemiology and molecular biology of PVs
- Animal models for the study of papillomavirus disease
- Basic immunology and pathogenesis of PVs
- Therapeutic and prophylactic vaccines
- Prevention of HPV associated cancers, particularly cervical cancer and other PV-associated diseases
- Promotion of the spread of the scientific knowledge to benefit the whole community

Our overarching theme will be harnessing the power of innovation from HPV research to deliver global prevention and control of HPV-related disease.

Barcelona is a hub for innovation and health research and a vibrant exciting city with a proud history and diverse cultural and pleasurable activities to offer.

See you at IPVC 2020!

Margaret Stanley (IPVS President) and Silvia de Sanjose
IPVC 2020 Co-Chairs
Meeting Website: View more information

3rd International Conference on Pharmaceutical Research & Innovations in Pharma Industry

Organization: Conference Series LLC Ltd
Event Date or Start Date: 3/23/2020
End Date: 3/24/2020
Event Type: Other Scientific Events
Country: SPAIN
State or Region:
Additional Meeting Information: 3rd International Conference on Pharmaceutical Research & Innovations in Pharma Industry (Pharma Research 2020) scheduled to be held during March 23-24, 2020, Barcelona, Spain. This Pharma Research 2020 Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. The conference invites delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Pharma Research 2020. International conference will be an excellent opportunity to meet eminent personalities in the fields of pharmaceutics and learn about the latest technological advancements. For more details visit: https://research.pharmaceuticalconferences.com/
Meeting Website: View more information

2nd Bacteriophage Therapy Summit 2020 - Boston, MA

Organization: Hanson Wade
Event Date or Start Date: 3/24/2020
End Date: 3/26/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: MA
Additional Meeting Information: The only industry-focused forum dedicated to facilitating the discovery, translation and acceleration of bacteriophage research into targeted therapeutics with clinically significant results.

As phage therapy offers an opportunity to tackle the ever-growing problem of antibiotic resistant infections, the 2nd Bacteriophage Therapy Summit returns to not only drive forward the translation of phage pharmacology into the clinic but also generate discussion around the direction that phage therapy is heading and how this can be commercialized and delivered into the hands of physicians and patients in need.

The 2nd Bacteriophage Therapy Summit is a dedicated scientific and networking forum for large pharma, biotechs and research institutes to capitalize on this re-emerging therapeutic class.

With a clear focus on overcoming the translational and development challenges of this re-emerging therapeutic class, join your peers to be part of the discussion to facilitate the translation of phage products into targeted, clinically successful therapeutics.

Early booking and group discounts apply, start-up and academic rates are available - see the website for details.
Meeting Website: View more information

Gene Therapy for Rare Disorders 2020

Organization: Hanson Wade
Event Date or Start Date: 3/30/2020
End Date: 4/2/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: MA
Additional Meeting Information: Gene therapies are redefining the treatment of rare diseases. However, a set of complex and unique challenges must be overcome for these therapeutics to achieve their commercial potential.

The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.

With approvals in a number of indications over the last year, and more rapidly approaching on the horizon, the meeting will leverage the experience from first to market pioneers, as well as unveiling the strategies
drug developers are employing to improve efficacy, safety and commercial viability.

Incorporating insights from 80+ industry-leading speakers, this conference will delve into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.

Join 600+ of your colleagues to accelerate the progress of the next generation of gene therapies.

This is your comprehensive guide to define your commercial path forward in 2020.

Early booking and group discounts apply. Please visit the website for more information.
Meeting Website: View more information

18th annual eyeforpharma Barcelona Conference

Organization: eyeforpharma
Event Date or Start Date: 3/31/2020
End Date: 4/2/2020
Event Type: Other Scientific Events
Country: SPAIN
State or Region:
Additional Meeting Information: The world's largest commercial pharma event comes back for its 18th annual year. We need a new kind of pharma leadership – one that is authentic, all about data-driven decision-making, regulatory-grade real-world evidence, value-based access and empowering medical on the front line. eyeforpharma Barcelona will help you affect this change.

Join 2000+ pharma decision-makers and healthcare innovators to:

- Ensure integrity and accuracy in decision-making and portfolio design. Gain healthcare’s trust through medically-driven content, customer innovation and holistic patient solutions
- Hit Commercial Goals: Turn HCPs into influencers and inspire patient champions. Use content, education, empowerment and open innovation to harness external relationships
- Use cloud platforms, data insights and JVs with start-ups to generate a new suite of digital products, value-added services and cell and gene therapies. Go from druggable and reactive to curable and preventative
- Prepare a superior mix of virtual clinical trials and regulatory-grade RWE to gain authorisation, widen access, boost launch and drive patient outcomes

Why you need to attend:

-9 dedicated conference streams: Barcelona is huge – 2000+ people in total. Yet it’s also intimate, tailored just for you. You’ll spend most of the conference in one of 9 tracks with sessions that hit all your buttons.
- All stakeholders. All functions. 1 place: The most cross-functional pharma event in the world – executives from marketing, commercial, sales, market access, medical affairs, patient engagement, RWE, IT, clinical and more.
- More than just conference sessions: Sometimes, the best ideas don’t come from the stage. They come from those chance happenings when you joined a roundtable or went to a networking evening.

Venue Details: Centre de Convencions Internacional de Barcelona, 11-14 Plaça de Willy Brandt, Barcelona, 08019, Spain

Meeting Website: View more information

First integrated international workshop on acetyltransferases, sulfotransferases, and UDP-glucuronosyltransferases

Organization: CLB-Envirome Institute, University of Louisville
Event Date or Start Date: 4/1/2020
End Date: 4/3/2020
Event Type: SOT-Sponsored Events
Country: UNITED STATES
State or Region: KY
Additional Meeting Information: The first integrated international workshop clearly is a novel proposal that builds upon the success of past international workshops that focused on a single xenobiotic metabolizing enzyme system. The opportunity to integrate the enzyme systems with the world’s leading scientists has never been proposed or accomplished to date. A key purpose and knowledge gap to be met by the integrated workshop is understanding the role of the xenobiotic metabolizing enzymes in environmental health as a group rather than individually. This integration theme was a key rationale for selection of many of the keynote speakers. In an era where powerful genomic technologies are accelerating research into the complex gene-environment interactions modulating the biological effects of xenobiotics (drugs, carcinogens etc.), it is critical to include other major families of phase II conjugation enzymes within the context of an integrated workshop. The first integrated international workshop on acetyltransferases, sulfotransferases and UDP-glucuronosyltransferases will open new channels of interaction and collaboration across a broader scientific community, invigorating the field and expanding its global impact. The workshop will provide important consensus information on the proper use of gene and allelic symbols, as well as for conveying recommendations by the HUGO Gene Nomenclature Committee, the PharmacoGenomics KnowledgeBase, the Human Genome Variation Society etc. The workshop will promote constructive discussion towards harmonization of pharmacogenetic nomenclature and test result reporting for phase II conjugation enzymes, a need recently recognized by an international workgroup of experts led by scientists of the US Centers of Disease Control and Prevention (Clin. Pharmacol. Ther. 2016, 99:172-85).
Meeting Website: View more information

2020 ASBMB Annual Meeting

Organization: American Society for Biochemistry and Molecular Biology (ASBMB)
Event Date or Start Date: 4/4/2020
End Date: 4/7/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: CA
Additional Meeting Information: At the 2020 ASBMB Annual Meeting, you’ll find a diverse community of scientists eager to learn about the work you’re doing — and the work you dream of doing. Present your latest findings, hear inspiring lectures, participate in workshops, and form new bonds that will help you achieve the most important work of your career. The ASBMB annual meeting is the nexus for those seeking lasting connections that yield transformative results.
Meeting Website: View more information

Nanomedicine and Drug Delivery

Organization: Frontiers Meetings Ltd
Event Date or Start Date: 4/13/2020
End Date: 4/15/2020
Event Type: Other Scientific Events
Country: JAPAN
State or Region: Tokyo
Additional Meeting Information: 2nd Global Experts Meeting on Nanomedicine and Drug Delivery (Nano Delivery-2020), is a CPD accredited international conference with the theme "Nanomedicine and Drug Delivery Systems (DDSs): Recent developments and future prospects" which will be held during April 13-15, 2020 in Tokyo, Japan is now an established event, attracting global participant’s intent on sharing, exchanging and exploring new avenues of Nanomedicine and Drug Delivery and related research and latest developments.
Dr. Hiroshi Maeda, Director, BioDynamics Research Foundation, Japan. The Most cited influential scientist in Chemistry and Pharmacology by Thomson Reuters, Creator of the world first polymeric-conjugate drug, SMANCS with H-index of 120, will be our Honorable guest and the Poster judge (Best Poster Award = USD 299).
For more PS: https://frontiersmeetings.com/conferences/nanomedicine/
This three-day international event will have 40+ world level plenary speakers and more than 10 Keynote Speakers including academicians and industry veterans. It’s a forum to explore problems popped up during real-time to the researches and come up with all sorts of awareness and solution-oriented discussions in the Pharmaceutical field.
Meeting Website: View more information

Extractables and Leachables USA 2020 Conference

Organization: Smithers
Event Date or Start Date: 4/20/2020
End Date: 4/22/2020
Event Type: Other Scientific Events
Country: USA
State or Region: MD
Additional Meeting Information: Smithers' 9th annual Extractables and Leachables USA Conference is returning to Bethesda, MD, April 20-22, 2020. This is a unique event in the E&L industry, bringing together top companies from the entire supply chain and making it easy to network with peers, leading to new, beneficial connections. The event is a must-attend for the extractables and elachables industry, wherein players need to stay on top of market changes, fluctuating regulations, medical device strategies, and safety standards for consumer safety and product success. Smithers' E&l 2020 gathers industry experts to discuss these topics, and more. The program consits of two days of industry-leading presentations by over 20 epert speakers, supplemented by valuable networking breaks, an included networking lunch, and a networking reception at the end of day one.
Meeting Website: View more information

11th Edition of International Conference on Food Safety, Hygiene And Regulatory Measures

Organization: EuroSciCon Ltd
Event Date or Start Date: 4/20/2020
End Date: 4/21/2020
Event Type: Other Scientific Events
Country: UNITED KINGDOM
State or Region:
Additional Meeting Information: To make event as the Euroscicon Ltd offers all the participants from all over the Globe to attend 11thInternational Conference on Food Safety and Regulatory Measures” during April 20-21, 2020 at London, UK. It includes prompt Keynote presentations, Oral presentations (Speaker forum and Young research forum), Poster presentations, and Exhibitions. This is going to be one of the most notable events of the year. It will bring all the Scientists, Professors and Delegates together for a remarkable success.
Meeting Website: View more information

The 6th Annual Translational Microbiome Conference

Organization: Arrowhead Publishers
Event Date or Start Date: 4/21/2020
End Date: 4/23/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: MA
Additional Meeting Information: Arrowhead Publishers is pleased to announce the return of its 6th Annual Translational Microbiome Conference to Boston on April 21-23, 2020, taking place at the Westin Copley Place. As the official conference of The Microbiome Coalition (TMBC), the Arrowhead Translational Microbiome Conference was the first microbiome conference in the field to focus exclusively on the hurdles and challenges to commercial success in the space.

Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer informative, hands-on workshops, panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.

Entering its 6th year in 2020, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
Meeting Website: View more information

6th Annual Formulation and Drug Delivery Congress

Organization: Oxford Global
Event Date or Start Date: 4/22/2020
End Date: 4/23/2020
Event Type: Other Scientific Events
Country: UNITED KINGDOM
State or Region: England
Additional Meeting Information: The Formulation and Drug Delivery Congress includes...

Over 300 pharmaceutical scientists working across formulation, drug delivery and manufacturing science and technologies, representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions

Over 60 presentations and case studies focused on the crucial issues in solid state dissolution, novel therapeutic development, delivery devices and combination products

PLUS interactive opportunities including:
- Roundtable discussions
- Panel discussions
- Pre-event podcasts and webinars

View Agenda: https://bit.ly/35bXlcC

Co-located with the 3rd Annual Inhalation and Respiratory Drug Delivery USA Congress.

For more information contact e.hawkings@oxfordglobal.co.uk.

Go Social: Join our Formulation and Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress and join the conversation at #FDDUK20

*2020 Live Webinar*

Patient-Centric Drug Development
19TH February 2020 10:30 AM - 11:30 AM GMT
Presented by Sven Steggemann, Professor for Patient Centric Drug Development and Manufacturing, Graz University of Technology
Register for free: https://bit.ly/2QFKSdk
Meeting Website: View more information

6th International Cancer Study & Therapy Conference

Organization: Madridge Publishers
Event Date or Start Date: 4/29/2020
End Date: 4/30/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: IL
Additional Meeting Information: Cancer Science-2020 is an initiative to unite the diverse researchers and business communities working in the field of cancer under one roof to understand the underlying biological procedures, current treatments which can be amended to increase effectiveness, precision, survivability and quality of life in cancer patients.
Meeting Website: View more information

SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference

Organization: SMi Group
Event Date or Start Date: 4/29/2020
End Date: 4/30/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: MA
Additional Meeting Information: SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, C.T.L. MAT, LONZA

CHAIRED BY: Lynne Ensor,VP Technical, Parexel

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding.

Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss the revision of Annex 1, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring and gain insight into an industry perspective on automated endotoxin testing and process automation.

HIGHLIGHTS FOR 2020:
• Discuss ongoing complication of personnel derived contamination from the FDA
• Gain valuable insight towards microbiological quality considerations in non-sterile manufacturing and control of BCC from Parexel
• Learn from the perspective of the US Pharmacopoeia on container closure integrity evaluation
• Examine an end-to-end contamination risk assessment for autologous cell therapy from Juno Therapeutics
• Explore a back to back Genentech session covering technical considerations for microbial QC of raw materials used in biotechnology and the past, current and future state of Mycoplasma testing

Post-Conference Workshop – May 1, 2020
The Use of Recombinant Chromogenic Assays as Alternate Methods for the Bacterial Endotoxins Test (BET)
Workshop Leader: Veronika Wills, Manager, Technical Services, Associates of Cape Cod

WHO SHOULD ATTEND:
Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist, Drug Substance External Manufacturer, QC Scientists, Heads of Quality, Business Development Manager, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist.

Prices:
Conference + 1 Workshop: USD 2498.00
Conference Only: USD 1999.00
Workshop Only: USD 499.00

Time: 8:30 am to 5:00 pm

Meeting Website: View more information

CPhI North America

Organization: Informa Markets
Event Date or Start Date: 5/5/2020
End Date: 5/7/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: PA
Additional Meeting Information: Over the last three years, CPhI North America has brought together more than 15,000 industry professionals across the entire pharmaceutical supply chain, including: custom chemicals, ingredients and manufacturing, contract services, finished dosage and formulations, machinery, technology, and packaging.
Meeting Website: View more information

Autoimmunity 2020, Athens: 12th International Congress on Autoimmunity

Organization: Kenes Group
Event Date or Start Date: 5/20/2020
End Date: 5/24/2020
Event Type: Other Scientific Events
Country: Please choose
State or Region:
Additional Meeting Information: With the history and experience of 11 International Congresses behind us, we are excited to welcome you to the 12th International Congress on Autoimmunity in Athens, Greece on 20-24 May 2020.

The unique scientific program of the Congress will bring you the latest updates in the field of autoimmune diseases, presented by the world's leading experts, while at the same time providing an amazing stage for young upcoming talents to present their research to a first-rate audience.

The 12th International Congress on Autoimmunity is the only meeting where you can learn about more than 80 autoimmune diseases from a variety of perspectives, both research-based and clinical. We will discuss the newest therapeutic techniques and diagnostic tools as well as the most up-to-date research on genetic, etiology, diagnostic, clinical aspects and novel therapies of autoimmune diseases.

Established by Professor Yehuda Shoenfeld, the congress constitutes a network of international leaders on immunology, rheumatology and related fields, all of whom contribute their unique and diverse knowledge to the "family of autoimmunity."

Abstract Submission Deadline: 3 December 2019
Meeting Website: View more information

SLAS Europe 2020

Organization: SLAS
Event Date or Start Date: 6/2/2020
End Date: 6/5/2020
Event Type: Other Scientific Events
Country: AUSTRIA
State or Region:
Additional Meeting Information: SLAS Europe 2020
2-5 June 2020
Vienna, Austria
https://slaseurope2020.org/
Venue: Messe Wien Exhibition & Congress Center

SLAS Europe 2020 provides a unique combination of education, access to innovative technologies and intelligent peer networking, delivering unmatched value for professionals and students looking to discover the latest life sciences technologies and how they can be applied to drive research objectives.

Meeting Website: View more information

2020 Gordon Research Seminar (GRS) and Conference (GRC) on Drug Safety

Organization: Gordon Research
Event Date or Start Date: 6/13/2020
End Date: 6/19/2020
Event Type: Other Scientific Events
Country:
State or Region: MA
Additional Meeting Information: Adverse events remain a significant hindrance to the drug development process. Thus, it comes as no surprise that improving the science supporting drug safety evaluation is imperative for improvement. To this end, the 2020 Gordon Research Seminar (GRS) and Conference (GRC) on Drug Safety are will be held June 13-14, 2020 followed by the GRC, June 14-19, 2020 at Stonehill College, Easton, MA. Save the date!
The GRS will be held in conjunction with the GRC to enhance the Gordon Conference experience for students, trainees and postdoctoral fellows. The GRS will be chaired by Molly Morgan, University of California San Diego, and Lauren Lewis, Texas A&M University, and is organized for new scientists with a focus on the effectiveness of their scientific presentations. A career development panel will be held to offer career advice and include leaders from different organizations (government, industry, and academia).
The GRC agenda will mirror the drug development pipeline with topics ranging from in silico computational approaches to clinical trials. The primary goal of the conference is to discuss different strategies to overcome safety challenges in drug discovery and development. Chaired by Myrtle Davis, Bristol-Myers Squibb and Mark Fielden, Expansion Therapeutics, the Drug Safety GRC is a multidisciplinary gathering of scientists from academia, industry, and government. For students and trainees, the conference serves as a career development opportunity and a chance to share their research results with experts in various fields through poster sessions and short talks. Social gatherings each evening allow time for in-depth and informal interactions with leading research scientists.
While the fees have not yet been finalized, the registration costs for the GRC and GRS include registration, all meals, and accommodations for the duration of the meeting. What a bargain! We are looking forward to having you attend and participate in these exciting meetings.
For more details and online registrations please visit us at:
https://www.grc.org/drug-safety-conference/2020/
https://www.linkedin.com/groups/7018869/
Meeting Website: View more information

AHR Symposium 2020: Toxicity to Therapeutics

Organization:
Event Date or Start Date: 6/14/2020
End Date: 6/18/2020
Event Type: SOT-Sponsored Events
Country: UNITED STATES
State or Region: PA
Additional Meeting Information: The AHR Symposium will bring together world-renowned scientists in an integrated program to share / discuss the latest knowledge on the role of the aromatic hydrocarbon receptor (AHR) in a wide range of fields.

This year, the symposium will be held on the Penn State University campus in State College, PA from June 14-18, 2020. The sessions will showcase cutting edge research and highlight advancements in the study of AHR in terms of public and environmental health, toxicology, pharmacology and biology of development. The themes of the symposium will therefore address many systems / models of pathologies related to environmental toxicology.

In addition to research presentations and poster sessions, the meeting will include an optional tour of local wineries on Sunday for early arrivals. On Monday, the meeting will open with Keynote presentations followed by a welcome reception. On Wednesday, join your friends and colleagues for a dinner and reception in the gardens at the Arboretum at Penn State.

Along with opportunities to network with colleagues from around the world and learn the latest scientific information, the Penn State campus and surrounding area offers many things to do and see. Central Pennsylvania is a beautiful part of the United States boasting scenic mountains, local culture, and a world class research institution. Come for the meeting, but make sure to take advantage of all the area has to offer.

For information about the Symposium and to register, visit the
Meeting Website: View more information

SCON International Conference on Stem Cells and Regenerative Medicine

Organization: Scholarena
Event Date or Start Date: 6/15/2020
End Date: 6/16/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: MO
Additional Meeting Information: The Congress is intended to bring together leading academics and scientists in the field of Regenerative Medicine to exchange and share relevant experiences in their practice. This would centre on presentations and discussions on research results on all aspects of Regenerative Medicine. It will also provide a platform for interdisciplinary researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns in their research efforts. Finally, the Congress will afford participants the time to disclose practical challenges they encountered, as well as the solutions they discovered in their field investigations in Regenerative Medicine.
Meeting Website: View more information

Global Conference on Pharmaceutics and Pharmacology

Organization: PAGES LLC
Event Date or Start Date: 8/6/2020
End Date: 8/7/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: TX
Additional Meeting Information: It is inarguable that pharmaceutical industry is of immense importance as a global sector. It is responsible for research, development, production and marketing of medications. This industry is anticipated to reach a market value of US$ 1.18 trillion by 2024 with a compound annual growth rate of 69 percent for the forecast period 2019-2024. Further research in this field will help in analyzing and evaluating future trends in drug development.

To explore foremost research in pharmaceutical sciences and to discuss clinical, analytical and commercial issues in pharmacology, Pages Conferences is organizing Global Conferennce on Pharmaceutics and Pharmacology, which will be held during August 06-07,2020 in San Antonio. The conference offers a seamless view of the industry today while paving way for future research.

The conference aims to empower future generations in different fields of pharmaceutics to explore exciting research outcomes that lie in tune with the objectives and theme of this exciting event. It further helps you enhance your understanding of commercial, scientific and regulatory issues that affect strategic decision making in the pharmacology sector.

Sessions Link: https://pagesconferences.com/pharmacology-pharmaceuticsconference/call-for-abstracts.php

Contact us:

Julie Andrieo
gcpp-2020@pagesconferences.com

Meeting Website: View more information

Global Conference on Toxicology

Organization: PAGES LLC
Event Date or Start Date: 8/6/2020
End Date: 8/7/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: TX
Additional Meeting Information: The Global ADME toxicology testing market is expected to witness a massive growth and reach US$ 10.25 billion by 2025 with a CAGR 11.4 percent. Increased need for more accurate testing by pharmaceutical companies and late-stage drug failure are primary factors fuelling this growth. Further research in toxicology testing procedures allows researchers in effective drug development while presenting innovation and growth opportunities.

To provide critical information and knowledge based on latest research in toxicology, Scientific Federation is organizing the Global Conference on Toxicology which is scheduled to be held during August 06-07,2020, in San Antonio, USA. The aim of this conference is to share critical toxicology information to protect public health.

For more information:

Satya | Program Manager
Toxicology-2020
gct-2020@pagesconferences.com

Meeting Website: View more information

Euro cardiology summit 2020

Organization: Genoteq Healthcare
Event Date or Start Date: 8/10/2020
End Date: 8/11/2020
Event Type: Other Scientific Events
Country: PORTUGAL
State or Region: Lisbon
Additional Meeting Information: We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of cardiology.
Cardiology is a branch of internal medicine . It is a study and treatment of disorder of heart and blood vessel. The term” heart disease” is often interchangeably with term cardiovascular disease. A person with heart disease or cardiovascular disease may refer to cardiologist. Cardiovascular generally refers to conditions that involved narrow and blocked vessels that can lead to a heart attack ,chest pain or stock .Other heart conditions such as those affects your heart muscle , valves or rhythm also consider forms as heart disease.
Meeting Website: View more information

SETAC 8th World Congress

Organization: SETAC
Event Date or Start Date: 9/6/2020
End Date: 9/10/2020
Event Type: SOT-Sponsored Events
Country: SINGAPORE
State or Region:
Additional Meeting Information:
Meeting Website: View more information

American Drug Delivery and Formulation Summit 2020, San Diego

Organization: Mark Allen Group
Event Date or Start Date: 9/14/2020
End Date: 9/15/2020
Event Type: Other Scientific Events
Country: UNITED STATES
State or Region: CA
Additional Meeting Information: The growth of biopharma and patient compliance issues have encouraged us to adopt a drug delivery mind set from discovery through to production.

Every year we see innovation and breakthroughs at every level of drug development.

The DDF Summit brings the most innovative and exciting studies to you.

Covering both small molecules and biologics, you'll find new technologies, concepts and case studies in areas such as...

- Formulation design for poorly soluble compounds
- The potential of nanotechnology for better deliverability
- The latest controlled released technologies
- Improving patient compliance by harnessing data and the latest smart device technology
- Optimising formulations for continuous manufacturing
- Overcoming the blood brain barrier and challenges in oral delivery of biologics
- Reformulation and biosimilars
Meeting Website: View more information